Collaborate Bipodex Collaborate

Radiotherapy Oncology

ONCOLOGY
BIOMARKERS CANCER TECHNOLOGY
TARGETS

Identification of prognostic biomarkers and predictors of response to oncological treatments in breast, lung, head and neck, colorectal and prostate cancers based on oxidative stress, metabolism and immunity, in order to advance personalization in oncology. Radiogenomics research. Studies of the anti-inflammatory effects of low-dose radiotherapy in benign pathology. Studies in relation to the technological advances of the different radiotherapy techniques (IMRT, VMAT, 4D, SBRT, among others).

RESPONSIBLE

  • Dra. Meritxell Arenas Prat

  • Presentation
  • Research lines
  • Group members
  • Projects
  • Publications
  • Clinical practice guidelines
  • Dissemination
  • Contact

The Radiotherapy Oncology Research Group of the Institute of Health Research Pere Virgili (IISPV) started in 2010 and it is constituted by a multidisciplinary team that is oncologists, physicists, nutritionists, engineers, nurses … with a care activity which is mainly devoted to patients with cancer. They belong to the Radiation Oncology Department of the Hospital Universitari Sant Joan de Reus (HUSJR) which is the Reference Health Center for cancer radiation treatment of patients diagnosed in the province of Tarragona, Spain, with a catchment area of a population of 813000 inhabitants. In 2020, 2100 patients were treated in the Service. The Radiotherapy Department treats patients from different hospitals in the province of Tarragona. The main line of basic research is “Predictive markers of response in breast cancer”. The RGRO also develops projects together with other research groups of the IISPV (Unitat de Recerca Biomèdica (URB)) and the Universitat Rovira i Virgili (URV). The group has published 150 articles indexed in journals with an international scope, as well as in more than 450 communications to national and international congresses.

The research team possesses broad experience in the study of metabolic changes mediated by mitochondrial dysfunction in breast cancer, lung, rectal and head&neck cancers after radiotherapy. The research team also collaborates with the Intelligent Robotics and Computer Vision group of the Universitat Rovira i Virgili in medical image analysis and machine learning studies.

An additional research line from the group is on the anti-inflammatory effects of radiation therapy at low doses in benign diseases.

  • Identification of biomarkers and prognostic and predictive biosensors in different types of cancer.
  • Radiogenomics in lung cancer and breast cancer.
  • Anti-inflammatory effects of radiotherapy in benign pathology.
  • Studies on the technological advances of radiotherapy.

  • Name of the project: Identification of biomarkers based on energy, metabolism, oxidative stress and immune system in patients with breast cancer.
    Entity where project took place: Institut d’Investigacions Sanitàries Pere Virgili, Reus
    Funding entity or bodies: Varian Ibérica, S.L. Tipo de entidad: Entidad Empresarial
    Start-End date: 07/09/2020 – 06/09/2021

    Duración: 1 año
    Total amount: 54.000 €

  • Name of the project: Radioterapia antiinflamatoria a dosis bajas para el tratamiento de la neumonía por covid- 19: estudio prospectivo multicéntrico (ipacovid).
    Entity where project took place: Institut d’Investigacions Sanitàries Pere Virgili, Reus
    Funding entity or bodies: Grupo de Investigación Clínica en Oncología Radioterápica
    Start-End date: 2020 – 2021

    Duración: 1 año

  • Name of the project: Biomarcadores en sangre de pacientes con cáncer de mama
    Geographical area: Regional
    Degree of contribution: Researcher
    Name principal investigator (PI, Co-PI….): Meritxell Arenas; Jorge Camps Andreu
    Start date: 2019

    Duración: 1 año
    Total amount: 11.000 €

  • Name of the project: Estudi del metabolismo energético, la oxidación y la inflamación como posibles biomarcadores de la respuesta al tratamiento con radioterapia en el cáncer de pulmón
    Geographical area: Regional
    Degree of contribution: Researcher
    Name principal investigator (PI, Co-PI….): Meritxell Arenas; Jorge Camps Andreu
    Start date: 2018

    Duración: 1 año
    Total amount: 11.000 €

  • Name of the project: Evaluar la probabilidad de la no adherencia al tratamiento de radioterapia externa y sus factores asociados en los pacientes tratados por cáncer en Cataluña.
    Entity where project took place: Pla Director d’Oncologia. ICO Hospitalet
    Start-End date: 03/10/2016 – 03/12/2018

    Duración: 3 años
    Total amount: 72.000 €

  • Name of the project: Proyecto IA-Biobreast: Anlálisis de caracteristicas texturales a nivel de pixel y fusión de información multimodal. Degree of contribution: Researcher
    Entity where project took place: Universitat Rovira i Virgili
    Funding entity or bodies: Ministerio de Economía y Economia
    Start-End date: 01/01/2012 – 31/12/2015

    Duration: 2 years
    Total amount: 23.595 €

  • Name of the project: Escaneo e Impresión 3D para el tratamiento radioterápico del cáncer de piel o tumores con afectación cutánea
    Degree of contribution: Researcher
    Name principal investigator (PI, Co-PI….): Meritxell Arenas Prat; Doménec Puig
    Start date: 01/01/2016

    Duration: 1 year – 11 months
    Total amount: 3.000 €

  • Name of the project: Biomarcadores pronósticos y predictivos de respuesta a la Radioterapia en el càncer de mama.
    Degree of contribution: Researcher
    Name principal investigator (PI, Co-PI….): Meritxell Arenas Prat; Jordi Camps
    Start date: 01/09/2015

    Duration: 2 years – 3 months
    Total amount: 3.000 €

  • Name of the project: Paraoxonasa-1 y MCP-1 como a possibles marcadores de la respuesta al tratamiento con radioterapia en pacientes con cáncer de cabeza y cuello localmente avanzado, pulmón inoperable y cáncer de mama.
    Degree of contribution: Researcher
    Name principal investigator (PI, Co-PI….): Meritxell Arenas Prat; Jorge Camps Andreu
    Start date: 2015

    Duration: 1 year – 11 months
    Total amount: 4.000 €

    Year

    Electrochemical immunoplatform to assist in the diagnosis and classification of breast cancer through the determination of matrix-metalloproteinase-9

    B Arévalo; A Ben Hassine; A Vallverde; V Serafín; J Garoz; A Montero-Calle; A González-Cortés; M Arenas; S Campuzano; J Camps; JM Pingarrón. 15/12/2020. PMID: 33592776. Índice de impacto: 5,33 Resultados relevantes: Q1

    DOI: 10.1016/j.talanta.2020.122054.

    Bowel disfunction in survivors of gynaecologic malignancies.

    Ribas, M. Bonet, L. Torres, M. Núñez, E. Jovell-Fernández, E. Aranda, H. Jervoise Andreyev.  Supportive Care in Cancer 14 March 2020.

    https://doi.org/10.1007/s00520-020-05402-3

    Estratificación, monitorización y control del riesgo cardiovascular en pacientes con cáncer

    Ana Martín García; Cristina Mitroi; Ramón García Sanz; Ana Santaballa Bertrán; Meritxell Arenas; Teresa m López Fernández. Documento de consenso de SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC y AECC. Revista Española de Cardiología (English ed.). (España): 12/2020. ISSN 1885-5857.

    DOI: 1016/j.rec.2017.11.002. PMID: 29203166.

    Fully Automated Breast Density Segmentation and Classification Using Deep Learning

    N Saffari; H Rashwan; A Mohamed; V Kumar Singh; M Arenas; B Herrera; D Puig. 12/2020.

    DOI: 10.3390/diagnostics10110988. PMID: 33238512.

    Low dose whole lung radiotherapy for older patients with corona virus 19 disease (COVID-19) pneumonitis: practical by the International Geriatric Radiotherapy Group

    N Nguyen; M Arenas; T Vuong; A Zamagni; V Vinh-Hung; P Lara; M Bonet; B Baumert. Journal of Medical Internet Research (JMIR). 12/2020.

    DOI:10.2196/preprints.23570

    Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging

    F Luciano; N Cabré; G Baiges-Gaya; S Hernández; A Hernández; E Rodríguez; M Arenas; J Camps; J Menéndez; J Joven. 12, 26/10/2020.

    DOI: 10.18632/aging.104154

    MRI prostate contouring is not impaired by the use of a radiotherapy image acquisition set-up. an intra- and inter-observer paired comparative analysis with diagnostic set-up images

    S Sabater; L López-Martínez; I Andrés; MR Pastor-Juan; A Rovirosa; Meritxell Arenas. Cancer/Radiothérapie. 23 – 5, 09/2020.

    DOI: 10.1016/j.canrad.2020.05.024

    Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease?

    PC Lara; NP Nguyen; D Macias-Verde; M Arenas; J Thariat. Recommendation of the International Geriatric Radiotherapy Group.Aging and Disease. 11 – 3, pp. 489 – 493. 12/08/2020.

    DOI: 10.14336/AD.2020.0506

    Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial.

    M Algara; M Arenas; J Marin; I Vallverdú; P Fernández-Letón; G Febrer; C Rubio; A Montero. Clinical and Translational Radiation Oncology. 24, pp. 29 – 33. 06/08/2020.

    DOI: 10.1016/j.ctro.2020.06.005

    Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?

    F Rodel; M Arenas; OJ Ott; C Fournier; AG Georgakilas; S Tapio; KR Trott; US Gailp.  Strahlentherapie und Onkologie. 196 – 8, pp. 679 – 682. 06/08/2020.

    DOI: 10.1007/s00066-020-01635-7

    Ongoing Trials of Low dose Radiation Therapy for Covid-19 Pneumonia: Studying the Past to Define the Future?

    A Montero; M Algara; M Arenas. . Journal of Clinical Trials. 10 – 6, pp. 433. 06/08/2020.

    DOI: 10.35248/2167-0870.20.S3.005

    Current functioning of cardio-oncology units in Spain. Clinical and Translational Oncology.

    C Mitroi; A Martín-García; JA Virizuela; M Arenas-Prat; R García-Sanz; T López-Fernández.  22 – 8, pp. 1418 – 1422. 03/08/2020.

    Índice de impacto: 2,73 Resultados relevantes: Q2 Clinical medicine Q3 Oncology 157/244

    DOI: 10.1007/s12094-019-02250-4

    Brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?

    Y Zhang; C Ascaso; A Herreros; S Sabater; M Arenas; A Biete; A Rovirosa. . Clinical and Translational Oncology. 22 – 8, pp. 1295 – 1302. 08/2020.

    Índice de impacto: 2,73 Resultados relevantes: Q2 Clinical Medicine Q3 Oncology 157/244

    DOI: 10.1007/s12094-019-02255-z

    Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in catalonia, spain

    JM Borràs; R Font; J Solà; M Macià; V Tuset; M Arenas; A Eraso; JA Espinàs.  Radiotherapy and Oncology. 08/2020.

    Índice de impacto: 4.8 Resultados relevantes: Q1 D1

    DOI: 10.1016/j.radonc.2020.08.002

    The 2018 assisi think tank meeting on breast cancer: International expert panel white paper.

    M Arenas; U Selek; O Kaidar-Person; P Poortmans. Critical Reviews in Oncology/Hematology. 151 – 102967, 15/07/2020. PMID: 32450277.

    Índice de impacto: 5,833 Resultados relevantes: Q1.

    DOI: 10.1016/j.critrevonc.2020.102967

    Electrochemical immunoplatform to improve the reliability of breast cancer diagnosis through the simultaneous determination of RANKL and TNF in serum

    A Vallverde; V Serafín; J Garoz; A Montero-Calle; A González-Cortés; M Arenas; J Camps; JM Pingarrón. Sensors and Actuators, B: Chemical. 314, 15/07/2020.

    Índice de impacto: 7,1 Resultados relevantes: Q1 D1

    https://doi.org/10.1016/j.snb.2020.128096

    Older cancer patients during the COVID-19 epidemic: Practice proposal of the international geriatric radiotherapy group

    NP Nguyen; V Vinh-Hung; B Baumert; A Zamagni; M Arenas; U Karlsson; J Thariat. 15/05/2020.

    Índice de impacto: 6,12 Resultados relevantes: Q1

    DOI: 10.3390/cancers12051287

    Low-Dose radiation therapy for benign pathologies

    L Torres-Royo; G Antelo-Redondo; M Árquez-Pianetta; M Arenas Prat. Reports of Practical Oncology and Radiotherapy. 25 – 2, pp. 250 – 254. 15/04/2020.

    DOI: 10.1016/j.rpor.2020.02.004

    SKIN-COBRA (Consortium for Brachytherapy data Analysis) ontology: The first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer.

    V Lancellotta; JL Guinot; B Fionda; A Rembielak; M Arenas; L Tagliaferri.  Journal of Contemporary Brachytherapy. 04/2020. Índice de impacto: 2,14 Resultados relevantes: Q2

    DOI: 10.5114/jcb.2020.94579

    Alterations in plasma concentrations of energy-balance-related metabolites in patients with lung, or head & neck, cancers: Effects of radiotherapy.

    Rodríguez-Tomàs; M. Arguís; M. Arenas; S. Fernández-Arroyo; M. Murcia; S. Sabater; L. Torres; G. Baiges-Gayà; A. Hernández-Aguilera; J. Camps; J. Joven.  J Proteomics. 20, 03/02/2020. DOI: 0.1016/j.jprot.2019.103605. PMID: 31841666.

    Índice de impacto: 3,5 Resultados relevantes: Q1.

    DOI: 10.1016/j.jprot.2019.103605

    Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice.

    Bonet; V. García; N. Farré; M. Algara; B. Farrús; J. Fernandez; V. Reyes; A. Eraso; A. Álvarez; MJ. Cambra; A. Pedro; J. Vayreda; C. Lemansky; F. Izar; M. Arenas. Rep Pract Oncol Radiother.25 – 1, pp. 113 – 116. 01/02/2020.

    DOI: 10.1016/j.rpor.2019.12.019 PMID: 31908604.

    Breast tumor segmentation and shape classification in mammograms using generative adversarial and convolutional neural network.

    Vivek Kumar Singh; Hatem A Rashwan; Santiago Romani; Farhan Akram; Nidhi Pandey; Md Mostafa Kamal Sarker; Adel Saleh; Meritxell Arenas; Miguel Arquez; Domenec Puig; others. Expert Systems with Applications. 139, pp. 112855 – 112855. Pergamon, 2020.

    Índice de impacto: 5,45 Resultados relevantes: Q1 D1

    DOI: 10.2174/1573405614666191115102318

    Low-dose radiation therapy: could it be a game-changer for COVID-19?

    A Montero; M Arenas; M Algara. Clinical and Translational Oncology. 2020.

    Índice de impacto: 2,88. Resultados relevantes: Q2 Clinical Medicine. Q3 Oncology 157/244.

    DOI: 10.1007/s12094-020-02401-y

    Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform.

    M Garranzio-Asensio; A Guzmán-Aránguez; E Povedano; M Arenas; E Barderas.  2020. DOI: 10.7150/thno.42507. PMID: 32194852.

    Índice de impacto: 8,579 Resultados relevantes: Q1 D1

    DOI: 10.7150/thno.42507

    Radiotherapy is safe in patients with implantable cardiac devices. Analysis of a systematic interrogation follow-up. Clinical and Translational Oncology

    V Lopez-Hondurria; A Rovirosa; T López-Fernández; M Arenas; S Sabater. . 2020. Índice de impacto: 2,88 Resultados relevantes: Q2 Clinical Medicine Q3 Oncology 157/244

    DOI: 10.1007/s12094-020-02374-y

    IAEA methodology for on-site end-to-end IMRT/VMAT audits: an international pilot study

    Kazantsev P, Lechner W, Gershkevitsh E, Clark CH, Venencia D, Van Dyk J, Wesolowska P, Hernandez V, Jornet N, Tomsej M, Bokulic T, Izewska J.
    Acta Oncol. 2020 Feb;59(2):141-148.

    DOI: 10.1080/0284186X.2019.1685128

    Is it time to redefine the role of low-dose radiotherapy for benign disease?

    Montero A, Sabater S, Rödel F, Gaipl US, Ott OJ, Seegenschmiedt MH, Arenas M.
    Ann Rheum Dis. 2020 Mar;79(3):e34.

    DOI: 10.1136/annrheumdis-2018-214873

    What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans

    Hernandez V, Hansen CR, Widesott L, Bäck A, Canters R, Fusella M, Götstedt J, Jurado-Bruggeman D, Mukumoto N, Kaplan LP, Koniarová I, Piotrowski T, Placidi L, Vaniqui A, Jornet N.
    Radiother Oncol. 2020 Dec;153:26-33.

    DOI: 10.1016/j.radonc.2020.09.038

    High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Montemuiño S, Dios NR, Martín M, Taboada B, Calvo-Crespo P, Samper-Ots MP, López-Guerra JL, López-Mata M, Jové-Teixidó J, Díaz-Díaz V, Ingunza-Barón L, Murcia-Mejía M, Chust M, García-Cañibano T, Couselo ML, Puertas MM, Cerro ED, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Couñago F.
    Rep Pract Oncol Radiother. May-Jun 2020;25(3):447-455.

    DOI: 10.1016/j.rpor.2020.03.006

    Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation postoperative endometrial carcinoma?

    Zhang; C. Ascaso; A. Herreros; J. Sánchez; M. Del Pino; A. Torné; Y. Li; S. Sabater; M. Arenas; A. Biete; Rovirosa. . Clin Transl Oncol.21, 15/12/2019. PMID: 31865604. Índice de impacto: 2,77. Resultados relevantes: Q2 Clinical Medicine Q3 Oncology 157/244

    DOI: 10.1007/s12094-019-02255-z

    Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy

    M. Arenas; S. Fernández-Arroyo; E. Rodríguez-Tomàs; S. Sabater; Y. Murria; M. Gascón; K. Amillano; M. Mele; J. Camps; J. Joven. Clin Transl Oncol. 2, 15/11/2019. DOI: 10.1007/s12094-019-02232-6. PMID: 31679126.

    Índice de impacto: 2,77 Resultados relevantes: Q2 Clinical Medicine. Q3 Oncology 157/244.

    DOI: 10.1007/s12094-019-02232-6

    Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    T. López-Fernández; A. Martín-García; I. Roldán; C. Mitroi; P. Mazón Ramos; P. Díez-Villanueva; M. Arenas. . Rev Esp Cardiol (Engl Ed). 72- 9, pp. 749 – 759. 15/09/2019. DOI: 1016/j.rec.2019.03.019. PMID: 31405794.

    Índice de impacto: 5,1 Resultados relevantes: Q1

    DOI: 10.1016/j.rec.2019.03.019

    Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.

    MJ Cambra; F Moreno; X Sanz; Ll. Anglada; V. Reyes; Meritxell Arenas; A. Pedro; R. Ballester; V. García; J. Casals; M. Cusidó; C. Jimenez; JM. Escribà; M. Macià; JM. Solé; A. Arcusa; MA. Seguí; S. Gonzalez; B. Farrús; A. Biete. Clin Transl Oncol.1, 15/07/2019. DOI: 1007/s12094-019-02168-x. PMID: 31264148.

    Índice de impacto: 2,77 Resultados relevantes: Q2 Clinical Medicine Q3 Oncology 157/244

    DOI: 10.1007/s12094-019-02168-x

    Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy

    E Rodríguez-Tomàs; M Murcia; M. Arenas; M. Arguís; M. Gil; N. Amigó; X. Correig; L. Torres; S. Sabater; G. Baiges-Gayà; N. Cabré; F. Luciano-Mateo; A. Hernández-Aguilera; I. Fort-Gallifa; J. Camps; J. Joven. Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy. Antioxidants (Basel). 15/07/2019. DOI: 3390/antiox8070213. PMID: 31295833.

    Índice de impacto: 5,01. Resultados relevantes: Q1 D1.

    DOI: 10.3390/antiox8070213

    The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice

    A Montero Luis; C Aristei; J Meattini; Meritxell Arenas; L Boersma; C Bourgier; C Coles; B Cutuli; L Falcinelli; O Kaidar Person; MC Leonardi; B Offersen; F Marazzi; S Rivera; L Tagliaferri; V Tombolini; C Vidali; P Poortmans. Critical reviews in oncology/hematology. pp. 207 – 213. Elsevier, 06/2019. ISSN 1040-8428. DOI: 1016/j.critrevonc.2019.04.016. PMID: 31092377.

    Índice de impacto: 5,8 Resultados relevantes: Q1

    DOI: 10.1016/j.critrevonc.2019.04.016

    An MRI comparative image evaluation under diagnostic and radiotherapy planning set-ups using a carbon fibre tabletop for pelvic radiotherapy.

    Sebastià Sabater; M.R Pastor-Juan; R Berenguer; E Lozano-Setien; I Andres; MI Tercero-Azorin; M Sevillano; E Jimenez-Jimenez; A Rovirosa; E Korte; Meritxell Arenas.  Cancer radiotherapie. Elsevier, 24/05/2019. ISSN 1278-3218. DOI: 1016/j.canrad.2019.01.001. PMID: 31133514.

    Índice de impacto: 1,1 Resultados relevantes: Q4.

    DOI: 10.1016/j.canrad.2019.01.001

    ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.

    Orit Kaidar-Person; Birgitte Vrou Offersen; Sandra Hol; Meritxell Arenas; Cynthia Aristei; Celine Bourgier; Maria Joao Cardoso; Boon Chua; Charlotte E. Coles; Tine Engberg Damsgaard; Dorota Gabrys; Reshma Jagsi; Rachel Jimenez; Anna M. Kirby; Carine Kirkove; Youlia Kirova; Vassilis Kouloulias; Tanja Marinko; Icro Meattini; Ingvil Mjaaland; Gustavo Nader Marta; Petra Witt Nystrom; Elzbieta Senkus; Tanja Skyttä; Tove F. Tvedskov; Karolien Verhoeven.  Radiotherapy and oncology. pp. 159 – 166. Elsevier, 17/05/2019. ISSN 0167-8140.

    DOI:  10.1016/j.radonc.2019.04.010. PMID: 31108277.

    Índice de impacto: 4,85 Resultados relevantes: Q1 / D1

    DOI: 10.1016/j.radonc.2019.04.010

    Are there enough radiation oncologists to lead the new Spanish radiotherapy?. Clinical & translational oncology.

    A Rodríguez; Mertixell Arenas; P.C. Lara; J. López-Torecilla; M Algara; A Conde; H Pérez Montero; J.L Muñoz; M.J Pèrez-Calatayud; C Ferrer; The Spanish Society of Oncology and Radiotherapy. SpringerLink, 03/04/2019. ISSN 1699-048X. PMID: 30941701. Índice de impacto: 2,77 Resultados relevantes: Q2 Clinical Medicine Q3 Oncology 157/244

    DOI: 10.1007/s12094-019-02095-x

    Challenges Facing Radiation Oncologists in The Management of Older Cancer Patients: Consensus of The International Geriatric Radiotherapy Group.

    Tiberiu Popescu; Ulf Karlsson; Vincent Vinh-Hung; Lurdes Trigo; Juliette Thariat; Te Vuong; Brigitta G. Baumert; Micaela Motta; Alice Zamagni; Marta Bonet; Arthur Sun Myint; Pedro Carlos Lara; Nam P. Nguyen; Meritxell Arenas. Cancers (Basel). 16/03/2019. ISSN 2072-6694. PMID: 30884827.

    Índice de impacto: 6,12 Resultados relevantes: Q1

    DOI: 10.3390/cancers11030371

    Effect of Radiation on the Expression of CVD-related miRNAs, Inflammation and Endothelial Dysfunction of HUVECs

    Roser Esplugas; Montserrat Bellés; Noemí Serra; Meritxell Arenas; Víctor Hernández; Joan Carles Vallvé; Victoria Linares. . Anticancer Research. 39 – 2, pp. 771 – 780. 02/2019. ISSN 1791-7530. DOI: 21873/anticanres.13174. PMID: 30711956.

    Índice de impacto: 1,99 Resultados relevantes: Q1 Clinical Medicine Q4 Oncology 203/244

    DOI: 10.21873/anticanres.13174

    Current Status of Cardio-Oncology in Spain: A National Multidisciplinary Survey (Situación actual de la Cardio-Oncología en España: encuesta nacional multidisciplinaria. Revista Española de Cardiología (English ed.)

    Ana Martín García; Cristina Mitroi; Ramón García Sanz; Ana Santaballa Bertrán; Meritxell Arenas; Teresa López Fernández. . 72 – 1, pp. 84 – 86. (España): 2019. ISSN 1885-5857. PMID: 29203166.

    Índice de impacto: 5,1 Resultados relevantes: Q1

    DOI: 10.1016/j.rec.2017.11.002

    Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer

    N Serra; R Esplugas; Meritxell Arenas; Montse Bellés; Marta Bonet; M Gascón; JC Vallvé; Victoria Linares. . Plos one. pp. e0217443. PloS one, 2019. ISSN 1932-6203. PMID: 31150454.

    Índice de impacto: 2,74 Resultados relevantes: Q1

    DOI: 10.1371/journal.pone.0217443

    Patients' view of the differences in topical creams for radiation dermatitis prevention. A pilot study of cosmetic properties. Reports of practical oncology and radiotherapy.

    Sebastià Sabater; R Leon; C Esteban; JL Añon; Meritxell Arenas.  pp. 347 – 354. Elsevier, 2019. ISSN 1507-1367. PMID: 31198411

    DOI: 10.1016/j.rpor.2019.03.006

    Robotic MLC-based plans: A study of plan complexity

    Masi L, Hernandez V, Saez J, Doro R, Livi L. . Med Phys. 2020 Dec 17. Epub ahead of print. PMID: 33332628.

    Impact factor: 3.317 Resultados relevantes: Q1.

    DOI: 10.1002/mp.14667

    What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans.

    Hernandez V, Hansen CR, Widesott L, Bäck A, Canters R, Fusella M, Götstedt J, Jurado-Bruggeman D, Mukumoto N, Kaplan LP, Koniarová I, Piotrowski T, Placidi L, Vaniqui A, Jornet N.  Radiother Oncol. 2020 Dec;153:26-33. Epub 2020 Sep 25. PMID: 32987045.

    Impact Factor: 4.856 Resultados relevantes: Q1.

    DOI: 10.1016/j.radonc.2020.09.038

    A novel procedure for determining the optimal MLC configuration parameters in treatment planning systems based on measurements with a Farmer chamber.

    Saez J, Hernandez V, Goossens J, De Kerf G, Verellen D.  Phys Med Biol. 2020 Jul 27;65(15):155006. PMID: 32330917. Impact Factor: 2.883 Resultados relevantes: Q1.

    DOI: 10.1088/1361-6560/ab8cd5

    IAEA methodology for on-site end-to-end IMRT/VMAT audits: an international pilot study.

    Kazantsev P, Lechner W, Gershkevitsh E, Clark CH, Venencia D, Van Dyk J, Wesolowska P, Hernandez V, Jornet N, Tomsej M, Bokulic T, Izewska J.  Acta Oncol. 2020 Feb;59(2):141-148. Epub 2019 Nov 20. PMID: 31746249. Resultados relevantes: Q2

    DOI: 10.1080/0284186X.2019.1685128

    Does deep inspiration breath hold reduce plan complexity? Multicentric experience of left breast cancer radiotherapy with volumetric modulated arc therapy.

    Russo S, Esposito M, Hernandez V, Saez J, Rossi F, Paoletti L, Pini S, Bastiani P, Reggiori G, Nicolini G, Vanetti E, Tomatis S, Scorsetti M, Mancosu P.  Phys Med. 2019 Mar;59:79-85. Epub 2019 Mar 6. PMID: 30928069.

    Impact Factor: 2.485 Resultados relevantes: Q2.

    DOI: 10.1016/j.ejmp.2019.02.018

    Plan quality improvement by DVH sharing and planner's experience: Results of a SBRT multicentric planning study on prostate.

    Villaggi E, Hernandez V, Fusella M, Moretti E, Russo S, Vaccara EML, Nardiello B, Esposito M, Saez J, Cilla S, Marino C, Stasi M, Mancosu P.  Phys Med. 2019 Jun;62:73-82. Epub 2019 May 10. PMID: 31153401.

    Impact Factor: 2.485 Resultados relevantes: Q2.

    DOI: 10.1016/j.ejmp.2019.05.003

    On the need for tuning the dosimetric leaf gap for stereotactic treatment plans in the Eclipse treatment planning system

    Vieillevigne L, Khamphan C, Saez J, Hernandez V.  J Appl Clin Med Phys. 2019 Jul;20(7):68-77. Epub 2019 Jun 21. PMID: 31225938; PMCID: PMC6612699.

    Impact Factor: 1.679 Resultados relevantes: Q3.

    DOI: 10.1002/acm2.12656

  • Documento de consenso conjunto SEC-SEOM-SEOR-SEHH-SEMG-AEEMT-AEEC en el
    manejo del riesgo cardiovascular en la práctica clínica. Miembro del grupo de trabajo
    Entidad de realización: Sociedad Española de Cardiología
    Fecha de inicio: 2020

  • Elaboración de la guía de Tumores esofágicos ICO-Praxis. Miembro del grupo de trabajo. Dr. Trilla.
    Entidad de realización: Institut Català d’Oncologia (ICO)
    Fecha de inicio: 2020

  • Elaboración de la guía para el manejo coordinado de trabajadores con cáncer y riesgo
    cardiovascular. Miembro del grupo de trabajo
    Entidad de realización: Sociedad Española de Cardiología
    Fecha de inicio: 2019

  • Elaboración de la guía de Linfomas ICO-Praxis. Miembro del grupo de trabajo. Dra. López.
    Entidad de realización: Institut Català d’Oncologia (ICO)
    Fecha de inicio: 2019

  • Participación en el proyecto de indicadores de calidad en Oncología Radioterápica.
    Miembro del grupo de trabajo
    Entidad de realización: Sociedad Española de Oncología radioterápica.
    Fecha de inicio: 2019

Team Members

  • Group leader

    • Dra. Meritxell Arenas Prat

  • PhD, MD

    • Víctor Hernández
    • Iván Henríquez
    • David Gómez

  • Predoctoral

    • Elisabet Rodríguez Tomàs

  • MD

    • Mònica Arguís
    • Johana Acosta
    • Junior Gómez
    • Laura Torres
    • Miguel Árquez
    • Fredy Castaño
    • Yolanda López Sánchez
    • Jorge Trilla Martín
    • Mauricio Murcia

  • Nurse

    • Irene Oliván
    • César Esteban
    • Rafa León

  • Administrative

    • Núria Cabré

Altres grups de Oncology

See all